Synergistische Effekte von Lonafarnib und Carboplatin auf humane Ovarialkarzinomzellen in vitro

Sich schnell entwickelnde Platinresistenzen gehören zu den ungelösten Problemen der Chemotherapie des Ovarialkarzinoms. Die Kombination von Carboplatin mit neuen Substanzen ist eine Möglichkeit, diesen Hindernissen zu begegnen. In dieser Arbeit wurde untersucht, ob sich in vitro synergistische Effe...

Full description

Saved in:
Bibliographic Details
Main Author: Stolze, Jennifer
Contributors: Wagner, Uwe (Prof. Dr.) (Thesis advisor)
Format: Doctoral Thesis
Language:German
Published: Philipps-Universität Marburg 2010
Subjects:
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents: The in-vitro effects of Carboplatin and Lonafarnib on the human Ovarian Cancer cell lines BG1 and SKOV-3, were investigated by proliferation assays, cell cycle distribution analysis, apoptosis induction assay and drug accumulation assys. The proliferation of both cell lines were inhibited in a time and dose dependent manner, calculation of the interaction index revealed drug synergism at distinct drug concentration combinations. Cell cycle distribution analysis showed an arrest in G2-M-phase of SKOV-3. Apoptosis induction assays showed an increase of apoptosis and necrosis in treated cells. Drug accumulation with Daunorubicin showed an increased accumulation after treatment with Lonafarnib alone and in combination with Carboplatin. Carboplatin alone lead to a decreased drug accumulation in the used cell lines. In conclusion it can be said that there are synergistic effects of Lonafarnib and Carboplatin in Ovarian Cancer cells in-vitro.